Pharming Group NV
AEX:PHARM

Watchlist Manager
Pharming Group NV Logo
Pharming Group NV
AEX:PHARM
Watchlist
Price: 0.7355 EUR 2.65% Market Closed
Market Cap: 498.9m EUR
Have any thoughts about
Pharming Group NV?
Write Note

Pharming Group NV
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pharming Group NV
Revenue Peer Comparison

Comparables:
PRQR
QURE
ARGX
MRUS
LVTX

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Pharming Group NV
AEX:PHARM
Revenue
$277.6m
CAGR 3-Years
-7%
CAGR 5-Years
5%
CAGR 10-Years
51%
ProQR Therapeutics NV
NASDAQ:PRQR
Revenue
€18.7m
CAGR 3-Years
143%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Uniqure NV
NASDAQ:QURE
Revenue
$28.6m
CAGR 3-Years
-61%
CAGR 5-Years
36%
CAGR 10-Years
18%
argenx SE
XBRU:ARGX
Revenue
$1.9B
CAGR 3-Years
44%
CAGR 5-Years
87%
CAGR 10-Years
126%
Merus NV
NASDAQ:MRUS
Revenue
$35.9m
CAGR 3-Years
-6%
CAGR 5-Years
1%
CAGR 10-Years
N/A
LAVA Therapeutics NV
NASDAQ:LVTX
Revenue
$6.8m
CAGR 3-Years
25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Pharming Group NV's Revenue?
Revenue
277.6m USD

Based on the financial report for Jun 30, 2024, Pharming Group NV's Revenue amounts to 277.6m USD.

What is Pharming Group NV's Revenue growth rate?
Revenue CAGR 10Y
51%

Over the last year, the Revenue growth was 35%. The average annual Revenue growth rates for Pharming Group NV have been -7% over the past three years , 5% over the past five years , and 51% over the past ten years .

Back to Top